Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00562016 · ClinicalTrials.gov registry record · Phase 3
Protect II, A Prospective, Multicenter Randomized Controlled Trial
A Phase 3 study, sponsored by Abiomed.
- Terminated
- Registry status
- Phase 3
- Development phase
- 452
- Enrollment target
NCT00562016: Clinical Trial Phase 3 study, sponsored by Abiomed.
NCT00562016 is a Phase 3 study that was terminated before completion, run by Abiomed. The registered enrollment target is 452 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00562016, a Phase 3 study, was terminated before completion, sponsored by Abiomed.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 452 participants
- Enrollment target
Study Summary
The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.
Interventions
- DEVICE IABP Intra-aortic balloon pump
- DEVICE IMPLELLA LP 2.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Why NCT00562016 stopped before completion
NCT00562016 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which IABP Intra-aortic balloon pump is the first listed.
NCT00562016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00562016 about?
NCT00562016 is a clinical study titled "Protect II, A Prospective, Multicenter Randomized Controlled Trial". The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.
What is the current status of trial NCT00562016?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 452 participants. The study started on 2007-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00562016?
The interventions under investigation include: IABP Intra-aortic balloon pump (DEVICE), IMPLELLA LP 2.5 (DEVICE).
Who is sponsoring clinical trial NCT00562016?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00562016's enrollment target sits among peer trials
452 835th of 2000 higher than 1,165 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia